Randox Laboratories Ltd. recalls Randox Rx Series Mg - Product Usage: For the quantitative in vitro determination of Magnesium in serum, plasma and urin…
- Recall date
- November 13, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0547-2021
- FDA classification
- Class II
- Brand / firm
- Randox Laboratories Ltd.
- Sold / distributed
- US Nationwide distribution in the states of GA, NJ.
Why it was recalled
Failing to meet the linearity performance claims quoted on the kit inserts-The linearity is reduced by approximately -30% for Serum/ Plasma and -50% for Urine
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Randox Rx Series Mg - Product Usage: For the quantitative in vitro determination of Magnesium in serum, plasma and urine Catalogue Number: MG8326
Get recall alerts
Free email alert whenever Randox Laboratories Ltd. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Randox Laboratories Ltd.